Raymond James & Associates Cytosorbents Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Cytosorbents Corp stock. As of the latest transaction made, Raymond James & Associates holds 50,000 shares of CTSO stock, worth $46,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,000

Previous 50,000 -0.0%

Holding current value

$46,000

Previous $35,000 114.29%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$1.08 - $1.94 $54,000 - $97,000	50,000 New	50,000 $55,000
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $152,240 - $278,530	-86,500 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$7.55 - $9.42 $993,202 - $1.24 Million	-131,550 Reduced 60.33%	86,500 $653,000
Q1 2021 May 14, 2021	BUY	$8.23 - $11.48 $2,057 - $2,870	250 Added 0.11%	218,050 $1.89 Million
Q4 2020 Feb 12, 2021	SELL	$7.65 - $8.98 $3,825 - $4,490	-500 Reduced 0.23%	217,800 $1.74 Million
Q3 2020 Nov 04, 2020	SELL	$7.37 - $11.54 $11,055 - $17,310	-1,500 Reduced 0.68%	218,300 $1.74 Million
Q1 2020 Apr 21, 2020	BUY	$3.77 - $7.73 $288,405 - $591,345	76,500 Added 53.38%	219,800 $1.7 Million
Q4 2019 Feb 12, 2020	SELL	$3.61 - $5.22 $276,165 - $399,330	-76,500 Reduced 34.8%	143,300 $552,000
Q3 2019 Nov 07, 2019	BUY	$4.33 - $7.63 $220,830 - $389,130	51,000 Added 30.21%	219,800 $1.11 Million
Q4 2018 Feb 11, 2019	BUY	$7.05 - $12.64 $137,475 - $246,480	19,500 Added 13.06%	168,800 $1.36 Million
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $200,385 - $270,840	-18,300 Reduced 10.92%	149,300 $1.93 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $3,450 - $6,175	500 Added 0.3%	167,600 $1.91 Million
Q1 2018 May 14, 2018	BUY	$6.55 - $8.2 $439,505 - $550,220	67,100 Added 67.1%	167,100 $1.18 Million
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $295,000 - $352,500	50,000 Added 100.0%	100,000 $650,000
Q2 2017 Aug 14, 2017	BUY	N/A	50,000	50,000 $215,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.7M

Call Options Held

28.9K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $40.1M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Cytosorbents Corp Transaction History